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ABSTRACT
Lytic development of bacteriophage Mu is con-
trolled by a regulatory cascade and involves three
phases of transcription: early, middle and late. Late
transcription requires the host RNA polymerase
holoenzyme and a 16.5-kDa Mu-encoded activator
protein C. Consistent with these requirements, the
four late promoters Plys,P I,P P and Pmom have recog-
nizable  10 hexamers but lack typical  35 hexam-
ers. The C protein binds to a 16-bp imperfect dyad-
symmetrical sequence element centered at  43.5
and overlapping the  35 region. Based on the crys-
tal structure of the closely related Mor protein, the
activator of Mu middle transcription, we predict
that two regions of C are involved in DNA binding:
a helix-turn-helix region and a b-strand region link-
ing the dimerization and helix-turn-helix domains.
To test this hypothesis, we carried out mutagenesis
ofthecorrespondingregionsoftheCgenebydegen-
erate oligonucleotide-directed PCR and screened
the resulting mutants for their ability to activate a
Plys-galK fusion. Analysis of the mutant proteins
by gel mobility shift, b-galactosidase and polyacryla-
mide gel electrophoresis assays identified a number
of amino acid residues important for C DNA binding
in both regions.
INTRODUCTION
Bacteriophage Mu is a temperate phage capable of growth
on many enteric bacteria, including Escherichia coli K-12
(E. coli). Upon infection, Mu DNA inserts almost ran-
domly into host DNA and then enters either a lysogenic
or lytic pathway (1–3). Expression of the Mu c repressor
protein is required for maintenance of the repressed
prophage in the lysogenic state. In the absence of repres-
sion or after heat induction of a cts mutant prophage,
phage development proceeds via a lytic pathway which
is controlled by a regulatory cascade involving three
phases of rightward transcription: early, middle and late
(4–6). Mu transcription is catalyzed by the host RNA
polymerase (RNAP) which is required throughout the
lytic cycle for the production of phage particles (7).
Early transcription initiates from Pe and requires neither
de novo protein synthesis nor Mu DNA replication (6,8).
Middle transcription initiates from the middle promoter
Pm and requires both DNA replication and Mor, an acti-
vator protein encoded by the Mu early transcript (5,6,9).
Late transcription requires the Mu C protein encoded by
the middle transcript; C activates transcription from the
four late promoters: Plys,P I,P P and Pmom (10–15).
Consistent with their need for an activator, the Mu late
promoters Plys,P I and PP contain  10 hexamers but lack
recognizable  35 hexamers (12) (Figure 1A). In Pmom the
sequence ACCACA is proposed to serve as a  35 element,
making the spacing between the  10 and  35 elements
19bp instead of the typical 17bp (16–18). DNAse I foot-
printing of Plys and Pmom showed that binding of C pro-
tein protects the region from about  30 to about  55
(15,18,19). Deletion mapping of plasmid-borne Plys
showed that Plys bases  60 to +8 (relative to the tran-
scription start site, +1) are suﬃcient for C-dependent
transactivation (20). Analysis of an extensive collection
of single base-substitution mutations in Plys indicated
that, in addition to the  10 region, a 19-bp region from
 52 to  34 containing the C footprint is required for
normal levels of C-dependent promoter activity (20).
Similar, more limited, analysis of the Pmom promoter
demonstrated the importance of this region in Pmom func-
tion as well (21). In both promoters this region contains
an imperfect dyad-symmetrical sequence element which
is proposed to serve as the binding site for a C dimer
(15,18,20,21). Consistent with this hypothesis, C was
found to form a dimer in solution in chemical crosslinking
and gel-shift experiments (19,22).
Work on the interaction of C with Pmom (23) and Mor
with Pm (24,25) suggests that there are both similarities
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show the bases protected by C protein in DNAse I footprinting experiments with Plys and Pmom (19,56). Inverted arrows indicate the proposed
dyad-symmetry elements required for C binding as determined from sequence inspection and properties of promoter mutants (20,21). The squiggly
arrow represents the start (+1) and direction of transcription (rightward). The shaded hexamer in Pmom identiﬁes the proposed  35 element. Below
the sequences are the consensus  10 and  35 hexamers with the spacing (17bp) for a typical E. coli promoter (16,17); capitalized positions are the
most important for promoter strength (16,17). (B) Amino acid sequence alignment of Mor and C proteins. The alignment shown was derived from a
15-member family alignment (29) with black and dark gray indicating invariant and chemically conserved residues, respectively, in that alignment.
Light gray shading shows additional residues that are identical or chemically conserved between C and Mor (shading has been left out from positions
in which residues are conserved in the 15-member alignment, but not in C and Mor). The two-headed arrows between the sequences show the amino
acids corresponding to the typical 20 amino acid HTH DNA binding motif (32). (C) Three plasmids used in this work (not drawn to scale). Plasmid
pYJ18 is the C expression plasmid with PT7 and PlacSYN driving transcription of the wild-type (pYJ18) and mutant C genes. The negative control
plasmid pYJ38 was made by deleting the C DNA segment between the NarI and HindIII sites. Plasmid pYJ12 is the reporter plasmid used for
screening C mutant properties; it expresses galK under Plys control and lacZ under Prep control. Finally, pLC18
S and pLC180 are the reporter
plasmids with lacZ transcribed under Plys control with promoter sequences  52 to +8 for pLC18
S and  60 to +8 for pLC180; they were used for
quantitative b-galactosidase assays reﬂecting the ability of the mutant C proteins to activate Plys.
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each protein to a proposed dyad-symmetrical sequence
element is critical for activation as are the immediately
adjacent downstream bases (20,21,25,26). Binding of C
caused modest DNA bending ( 208–408), and each pro-
tein generated hypersensitive sites in footprinting assays
carried out with and without RNAP (19,21,26). In the case
of Mor-dependent activation of Pm, the C-terminal
regions of both the alpha (a) and sigma (s) subunits of
RNAP are needed for optimal activation (24); whereas
neither is required for C-dependent activation of Pmom
(23). The C protein plays at least two roles in activation
of Pmom; C binding to Pmom leads to recruitment of RNAP
and also facilitates promoter escape (27).
The Mu C protein is a small protein of 140 amino acids
(16.5kDa) which shows considerable sequence similarity
to the Mu Mor protein, the activator of middle transcrip-
tion (9). Previous BLASTP (28) analysis identiﬁed 13
additional Mor/C homologs, predominantly in prophage
sequences in bacterial genomes, making Mor and C the
founding members of a new family of transcription fac-
tors (29). Recent BLASTP analyses identiﬁed more than
40 family members (data not shown). These proteins
are small ( 100–150 amino acids) and exhibit a prepon-
derance of acidic amino acids in the N-terminal half,
basic amino acids in the C-terminal half, and a predicted
helix-turn-helix (HTH) DNA-binding motif near the
C-terminus as shown in Figure 1B (9,11,13,30–32).
The crystal structure of Mor protein for Mor amino
acids 27 to 120 was determined to 2.2 A ˚ resolution (29).
The structure (Figure 2A) contains a Mor dimer with a
single dimerization domain formed by the intertwining of
helices a1 and a2 of both monomers to form a 4-helix
bundle. Flanking that central domain are the two HTH
domains, one from each monomer. In the linker between
the two domains of each monomer there is a b-strand
which interacts in an anti-parallel fashion with the
b-strand of the other monomer. In this structure, the
side chains of conserved b-strand residues Q68 and Y70
of Mor extend away from the protein (Figure 2B),
and those of the hydrophobic residues V69, I71 and P72
point toward the hydrophobic interior, forming a cap on
the dimerization domain. When the structural coordinates
of the HTH domain of Mor were compared with those of
other proteins, the TrpR protein HTH region was the
most similar (r.m.s.d. 1.5), leading to the prediction that
Mor, like TrpR, would use ‘ends on’ base recognition
binding by residues in the central turn of the HTH motif
and in the N-terminal region of the following recognition
helix (Mor a5) to interact in the DNA major grooves.
Since those HTH regions were too far apart to contact
two adjacent major grooves, Kumaraswami et al. (29)
proposed that the protein would undergo a conforma-
tional change in which the HTH domains would be
rotated up away from the dimerization domain and
closer together to contact bases in the DNA major
groove (Figure 2D). That conformational change could
bring the b-strands close to the DNA minor groove
located between the two major grooves, potentially allow-
ing interaction of side chains Q68 and Y70 with the minor
groove and intercalation of one or more nearby hydro-
phobic residues into the minor groove.
To test whether the predicted b-strand and HTH
regions of C are important for its DNA binding we
used degenerate oligonucleotide mutagenesis of both
the b-strand and HTH regions, screened for activation-
deﬁcient mutants, and then characterized the properties
of the mutant proteins in vivo and in vitro. The results
support the prediction that the regions containing both
the predicted HTH motif and b-strand are important for
DNA binding by C.
MATERIALS AND METHODS
Media, chemicals and enzymes
Minimal medium was M9 (33) supplemented with vitamin
B1 and a carbon source, as well as amino acids and
antibiotics when needed; minimal plates contained in addi-
tion 1.5% Bacto-agar (Difco laboratories, Detroit, MI,
USA). Minimal medium supplemented with 0.2% casa-
mino acids (M9CA) was used for b-galactosidase assays
(33) and protein over-expression. Liquid Luria broth
(LB) and LB plates (5) were used for routine cell growth
purposes. MacConkey lactose or galactose plates contain-
ing only 0.5% sugar (half the normal amount) were made
with 40g Difco MacConkey Agar Base and 5g lactose or
galactose per liter.
Ampicillin (Ap; U.S. Biochemical Corp., Cleveland
OH, USA) and chloramphenicol (Cm; Sigma Chemical
Co., St. Louis, MO, USA) were used as necessary at 50
and 25 mg/ml, respectively, unless indicated otherwise.
Isopropyl-b-D-thiogalactopyranoside (IPTG) and o-nitro-
phenyl-b-D-galactopyranoside were from American Bioor-
ganics Inc., Niagara Falls, NY, USA. Radiolabeled
compounds were purchased from DuPont NEN, Boston,
MA, USA. Acrylamide, bisacrylamide, N,N, N0,N0-tetra-
methylethylenediamine and protein molecular mass mar-
kers were from BioRad, Hercules, CA, USA. Ammonium
sulfate, polyethyleneimine (PEI), phenylmethylsulfonyl
ﬂuoride (PMSF), NP-40 and 2-deoxygalactose were from
Sigma Chemical Co. Both SeaKem ME and NuSieve
GTG agarose were from FMC Bioproducts, Rockland,
ME, USA.
Shrimp alkaline phosphatase, dNTPs, Sequenase 2.0,
labeling and termination mixes were from U.S. Biochem-
ical Corp (USB). The enzymes EcoRI, BamHI and Taq
polymerase were from Boehringer Mannheim Biochem-
icals, Indianapolis IN, USA; T4 polynucleotide kinase
was from Promega Corporation, Madison, WI, USA;
other restriction enzymes were from New England Bio-
Labs, Beverley, MA, USA. All enzymes were used accord-
ing to the manufacturer’s recommendations.
Bacterial strains andstrain construction
The bacterial strains used are all derivatives of E. coli K12
strain JM109 (mcrA proAB-lac thi gyrA endA hsdR relA
supE44 recA/F0 traD36 lacI
Q lacZDM15 proAB
+). Strain
MH13312, containing a diﬀerent F0 factor, F0 pro
+ lacI
Q1
DlacZY, was the host strain used for in vivo b-galactosi-
dase assays following introduction of the promoter and
6398 Nucleic Acids Research, 2008, Vol. 36, No. 20Figure 2. (A) The Mor dimer structure (amino acids 27–120) viewed from above with one monomer red and the other yellow. The secondary
structure elements, a helices 1–5 and b-strand 1 are numbered from amino acid 27 through amino acid 120; a and b numbers with a prime are in the
second monomer. (B) The Mor dimer structure viewed from the side. Side chains of key amino acids are shown in a ‘ball and stick’ representation
with 65G and 66G shown in red, 68Q in blue, 70Y in yellow, 72P in magenta and 74G in green. (C) The structure of the HTH domain of Mor
protein with side chains shown for amino acids predicted to be involved in DNA binding. (D) Conformational changes predicted to occur in both
Mor and promoter DNA for stable DNA binding. The helices a-1 and a-2 of the Mor dimerization domain are shown as cylinders; the b-strands as
arrows, and the HTH domains as ribbons. Thin black arrows point from the vicinity of the predicted DNA binding amino acids to the two adjacent
major grooves typically contacted by HTH motifs (48–50). The DNA (in purple) shows the predicted curvature away from the protein upon Mor
binding. Images in A, C and D are used with permission from the Mor structure paper by Kumaraswami et al. (29). (E) Mutagenesis of the predicted
DNA-binding regions of C. The heavy solid line represents the 140 amino acids of C protein, with dots at 10 amino acid intervals. Upside-down
triangles indicate the positions of unique pre-existing restriction sites (in parentheses below) and new sites introduced to facilitate cassette mutagenesis;
from the left end and proceeding rightward these triangles indicate restriction sites NdeI, MunI, ClaI, XhoI, SalI, AﬂII, SacI, BpuI102I, NarI, DraIII,
(BstXI), BanII, (BglII), BsshII, HindIII and (AatII). The secondary structure elements, a helix (oval) and b-strand (arrow), from the crystal structure of
Mor are shown at their corresponding positions in C as shown in Figure 1B; the dashed oval represents an additional a helix in C that was predicted
by the protein structure prediction program PHD (57). The HTH near the C-terminus indicates the positions of the helix-turn-helix DNA-binding motif
as predicted by the method of Dodd and Egan (30,31). Brackets with Roman numerals at the top of the ﬁgure show the regions mutagenized in the
three diﬀerent cassettes. The arrows and numbers below the solid line identify the amino acid positions with single amino acid changes; the letters
indicate the wild-type amino acid and mutant amino acid at that position, respectively, using the single letter amino acid code.
Nucleic Acids Research, 2008, Vol. 36, No. 20 6399protein expression plasmids (26). Strain MH12802 is
JM109 containing the pLC3 plasmid, which encodes
C protein under the control of a PlacUV5 promoter (20).
Strains MH13708 and MH14607 were made by transfor-
mation of MH13312 with plasmids pLC18
S or pLC180,
respectively. Strain MH13355 is a derivative of
JM109(DE3), containing a diﬀerent F0 factor, F0 pro
+
lacI
Q1 DlacZY and the lambda DE3 prophage encoding
phage T7 RNAP under PlacUV5 control (26). A sponta-
neous galK mutant derivative of MH13355, designated
MH13881, was selected by its resistance to 2-deoxygalac-
tose (34) by plating on minimal plates containing 0.2%
each of 2-deoxygalactose and glycerol and then screening
of resistant mutant colonies on MacConkey galactose
plates for a Gal
  mutant (white colony) that became
Gal
+ (red colony) upon transformation with plasmid
pYJ12 containing a wild-type galK gene. The derivative
of MH13881 carrying pYJ12, MH13906, was used in
assays of promoter activation by mutant C proteins.
Plasmids andplasmid construction
Plasmid pLC1 is a lacY derivative of the promoterless
lacZ fusion vector pRS415 (35) generated by deletion of
the SnaBI fragment in lacY (20). Cloning of a promoter
into the EcoRI-SmaI-BamHI linker in pLC1 or pRS415
generates a promoter-lacZ fusion suitable for analysis of
promoter activity. Plasmid vector pIA12 is a derivative of
pLC1 with an additional unique HindIII site located just
upstream of the EcoRI site (26). Plasmid pLC180
(Figure 1C) is a new derivative of pLC1 with the lacZ
gene under the control of the Mu Plys promoter ( 60 to
+8). Plasmid pLC18
S (made previously and designed to
be identical to pLC180) was recently found to contain
only Plys sequences  52 to +8. Comparison of the two
plasmids showed only minor diﬀerences:
(i) induction of wild-type C in vivo resulted in only
slightly ( 23%) higher promoter activity from
pLC180 (9506 604) than from pLC18
S
(7705 821), and
(ii) gel shift assays with both promoter sequences using
crude extract and puriﬁed C protein gave shifted
bands of similar intensity (19).
The transactivator plasmid pZZ13, derived from
pACYC184 (36,37), has the Mu C gene under the control
of both PlacUV5 and PT7 promoters (19). Plasmid pZZ41 is
similar to pZZ13 except that a more repressible synthetic
Plac promoter, designated PlacSYN, was substituted for
PlacUV5 (19).
Unique silent restriction sites were introduced into the
C gene to facilitate subsequent cassette mutagenesis. The
approach involved multi-step PCR with oligonucleotides
containing site-directed mutations, followed by restriction
digestion and cloning into existing NdeI, BstXI and
BamHI sites in or ﬂanking the C gene in pZZ13. Then,
the NdeI-BamHI fragment containing the entire C gene
was cloned into pZZ41 replacing the wild-type C gene to
generate the ﬁnal C expression vector pYJ18 (Figure 1C).
DNA sequence analysis conﬁrmed that pYJ18 contains the
desired restriction sites and encodes C protein with the
wild-type C amino acid sequence. A control experiment
showed that plasmids pYJ18 and pZZ41 promoted similar
levels of Plys-lacZ transactivation in vivo as shown by rela-
tive b-galactosidase units of 1000:861 for pYJ18:pZZ41 as
assayed in strain MH13708 containing the pLC18
S repor-
ter plasmid. Oligonucleotide sequences, restriction sites
and details of the construction will be provided upon
request. The negative control plasmid, pYJ38, which is
missing most of the C gene, was derived from pYJ18 by
deleting the NarI-HindIII fragment from C.
Plasmid pYJ12 was constructed to facilitate the screen-
ing of mutant C protein activity by colony color on
MacConkey plates; it contains two reporter systems: a
Plys-galK fusion to assay promoter activation by C and a
Prep-lacZ fusion to assay DNA binding by C by its ability
to repress the constitutive synthetic promoter Prep. First,
the 1686-bp PstI-EcoRI fragment from the Prep-lacZ plas-
mid pYJ3 containing ﬁve copies of the TI terminator was
cloned into the promoterless galK transcription fusion
vector pKO4 (38,39) to generate pYJ6. Then, Plys was
introduced between the terminator and galK gene by clon-
ing the pLC18
S Plys EcoRI-BamHI fragment into corre-
sponding sites of pYJ6 to generate pYJ7. The unique
restriction sites BsmBI and DraII in pYJ7 were changed
to unique SalI and XbaI sites by cloning an adapter. To
prepare the Prep-lacZ plasmid pYJ3 to receive the Plys-galK
fusion, an XbaI linker was cloned into the SnaBI site of
pYJ3 to create pYJ8. Finally, the 2480-bp XbaI-SalI
fragment from pYJ11 was cloned into pYJ8 to generate
pYJ12.
Figure 2. Continued.
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Oligonucleotides were synthesized by the University of
Tennessee Molecular Resource Center on an Applied
Biosystems (Foster City, CA, USA) DNA synthesizer
(Model 380B) using the phosphoramidite method (40).
For each degenerate oligonucleotide primer (20,41),
degeneracy was introduced into a 45–47nt targeted
region and synthesis was accomplished with a mixture of
98% of the correct phosphoramidite and 2% of a 1:1:1:1
mixture of dA, dC, dG and dT phosphoramidites to yield
on average 0.8 mutations per DNA strand. For site-spe-
ciﬁc mutagenesis the desired nucleotides were used for
synthesis at the appropriate positions. When necessary,
restriction sites for cloning were added at the 50-ends of
primers and were preceded by three to six bases for eﬃcient
digestion. Oligonucleotides were puriﬁed by ether extrac-
tion and ethanol precipitation (20) prior to use. The
sequences of oligonucleotides will be provided upon
request.
Mutagenesis and mutation identification
Three regions of the C gene in pYJ18 were mutagenized by
cloning three separate cassettes made by PCR with oligo-
nucleotides containing degeneracy in speciﬁc targeted
regions (20,41). The primers (YJ24, YJ26 and YJ27 for
regions I, II and III, respectively) were used with conve-
nient wild-type opposing primers in separate PCR reac-
tions, and the products were cloned into pYJ18 by using
restriction enzymes whose sites ﬂanked the cassette. Strain
MH13906 containing the Plys-galK,P rep-lacZ reporter
plasmid (pYJ12) was transformed with each ligation mix-
ture, and transformants were selected by plating on
MacConkey galactose indicator plates containing ampicil-
lin and chloramphenicol but lacking IPTG. White Gal
 
colonies containing C plasmids defective for Plys activa-
tion were then assayed for C-dependent repression of the
constitutive promoter Prep by streaking on MacConkey
lactose (with only 0.5% lactose) plates with and without
10
 2mM IPTG to induce moderate levels of C produc-
tion. By design, colonies that were red on both plates (with
and without IPTG) were to contain plasmids with candi-
date DNA binding-defective mutations in C; in practice
this repression assay was found to be unreliable, so the
next assay used for mutant characterization was SDS-
PAGE (42) to determine the size of the over-expressed
mutant C protein, and examination of the mutants for
DNA binding was deferred to a later step.
Plasmid templates for sequencing were isolated using
a QIAprep spin puriﬁcation kit (Qiagen, Valencia, CA,
USA) or a standard alkaline denaturation DNA miniprep
procedure (43). Templates were denatured in 0.2M NaOH
for 10min at 658C, neutralized, ethanol precipitated
and sequenced with Sequenase (USB) and dideoxynucleo-
tides using standard USB protocols. The mixtures
were run on 6% polyacrylamide sequencing gels, which
were ﬁxed, dried and exposed to X-OMAT AR ﬁlm
(Kodak, Rochester NY, USA) to visualize the band
pattern.
Characterization ofmutant proteins
Protein production and detection. Derivatives of strain
MH13881 carrying pYJ18 or its C-mutant forms were
grown to  2 10
8cells/ml at 378C in LB medium
and induced with 1mM IPTG for 90min. Cells from
0.5ml of culture were collected by centrifugation
(9000g for 10min), resuspended in 100ml buﬀer H
(25mM HEPES, pH 7.5 at room temperature; 0.5mM
EDTA, 0.5mM dithiothreitol, 0.5mM MgCl2,1 m M
CaCl2, 50mM NaCl, 5% glycerol, 0.1% NP40) and
lyzed by boiling in 125ml of sample buﬀer (42). Then,
40-ml portions were subjected to electrophoresis on 15%
polyacrylamide gels containing sodium dodecyl sulfate
(SDS PAGE) and stained with Coomassie blue to
detect the sizes and levels of the mutant C proteins.
For preparation of crude extracts for gel retardation
assays, overnight LB cultures of the above strains were
diluted 1:33 into 50ml M9CA minimal medium supple-
mented with 25mg/ml Cm and grown at 378Ct oa nA600
of 0.6. After addition of IPTG to 1mM, the cells were
grown for 90min at 378C, collected by centrifugation
(9000g for 10min), resuspended in 5ml buﬀer H and
lyzed by sonication. Cell debris was removed by centrifu-
gation at 9000g for 10min, and the supernatant, desig-
nated crude extract, was distributed into aliquots, and
stored at  708C. The relative concentration of C protein
in each extract was estimated by electrophoresis in 15%
PAGE with SDS in Tris glycine buﬀer for about 4h,
followed by staining with Coomassie blue (42), visual
comparison of C protein staining intensity, and dilution
of the extracts to achieve comparable amounts of C pro-
tein in each sample.
Analysis of DNA binding activity. The ability of C pro-
teins to bind to Plys was determined by a gel retardation
assay performed essentially as described by Carey (44)
utilizing a probe containing Plys sequence  52 to +8
made by PCR from pLC18
s with
32P-labeled oligonucleo-
tides LIL1 and LIL2 (20). Probes were puriﬁed by using a
QIAquick spin PCR puriﬁcation kit (Qiagen), and their
concentrations were determined on an ethidium bromide
stained agarose-mini gel (45). Binding reactions contained
10–20ng of probe and were conducted in 40ml of modi-
ﬁed buﬀer H containing 1% NP40 and 7% glycerol
for 15min at room temperature. Reactions were loaded
on 10% acrylamide gels (29:1), 0.5  TBE, and run for
4hr at 88C at 15V/cm. Gels were exposed overnight to
X-OMAT AR ﬁlm (Kodak) without drying.
Quantitative assay for transcription activation. Plasmid
pYJ18 and its C-mutant derivatives were transformed
into strain MH13708 containing the Plys-lacZ reporter
plasmid pLC18
s for Plys activation assays (Figure 1C).
Cells were grown in 10ml of M9CA to A600 0.3–0.5 at
378C, induced for C production by addition of IPTG to
2mM and grown at 378C for 1hr. Uninduced controls
and a wild-type C control culture were included in each
set of assays. Assays for b-galactosidase were performed
as described by Miller (33) with minor modiﬁcations (20).
The b-galactosidase units were calculated and normalized
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(set to 1000U) to minimize the eﬀect of day to day varia-
tion; values over 10 days for activation of the reporter
pLC18
s by wild-type C ranged from 6256 to 9185 Miller
units with an average of 7705 821.
RESULTS
Designof mutagenesis and reporter plasmids
Two plasmids were constructed, one (pYJ18) to allow eﬃ-
cient production of C mutants by cassette mutagenesis
and the other (pYJ12) to facilitate detection of the DNA
binding and transactivation abilities of the mutant C pro-
teins. The cassette mutagenesis plasmid pYJ18 contains a
modiﬁed C gene, which was altered by introduction of a
number of unique ‘silent’ restriction sites as described in
Materials and methods section (Figure 2E). These sites are
called ‘silent’ because the C protein encoded by pYJ18
has the wild-type C amino acid sequence; pYJ18 produces
slightly better than normal transactivation activity in vivo
(see Materials and methods section). Plasmid pYJ18 car-
ries this altered C gene under both PlacSYN and PT7 con-
trol. Induction of PlacSYN with IPTG leads to production
of relatively physiological levels of C protein for assays of
activation in vivo. In a host containing  DE3, which car-
ries the T7 RNA polymerase gene under PlacUV5 control,
IPTG induction leads to substantial overproduction of C
which is lethal to the host cell but suitable for preparation
of crude extracts for gel-shift analysis, estimation of C
protein size and quantity, and puriﬁcation of C protein.
The second plasmid, pYJ12, carries two reporter sys-
tems: a Plys-galK fusion to assay promoter activation by
Ca n daP rep-lacZ fusion to assay binding of C to DNA by
its ability to repress the constitutive promoter Prep.P rep is
a synthetic promoter which contains a perfectly symme-
trical strong C binding site overlapping the  10 and +1
region of the promoter such that binding of C represses
transcription. As designed, introduction of mutagenized
derivatives of pYJ18 into a host strain carrying pYJ12
(MH13906) would allow for fast and convenient assays
for C DNA binding and transactivation functions by the
colony color on MacConkey galactose and MacConkey
lactose indicator plates. Transactivation-defective mutants
would give white colonies on MacConkey galactose plates;
whereas, DNA binding-defective mutants would give red
colonies on MacConkey lactose plates. In practice, the
screening assay for transactivation worked very well,
allowing detection of mutants with varying levels of trans-
activation by the range of colony colors on MacConkey
galactose plates. In contrast, the Prep repression assay was
suﬃciently leaky that all colonies eventually turned red,
so its use was limited to early stages of mutant isolation.
Mutagenesis
The mutagenesis strategy was to target mutations speciﬁ-
cally to the b-strand and HTH regions of the C gene using
three degenerate oligonucleotide primers. PCR with pairs
of one wild-type and one degenerate primer (20,46) was
used to generate the three populations of mutant cassettes
which were cloned into the C gene in the expression vector
pYJ18, replacing the wild-type sequence in thatregion. The
primers were synthesized under conditions predicted to
result in a 1.5% mis-incorporation rate per nucleotide
over the mutagenized region, producing primer popula-
tions that on average should have  44% with wild-type
sequence,  36% with single mutations,  15% with double
mutations and  5% with more than two mutations (46).
The mutagenized plasmid libraries were transformed
into MH13906 (containing pYJ12; Figure 1C) and trans-
formants were screened for transactivation of the Plys-galK
fusion on MacConkey galactose plates. The transformants
were next assayed for the size and quantity of C protein
produced by using SDS-PAGE and Coomassie staining
of proteins from IPTG-induced cells lyzed by boiling in
sample buﬀer. As shown in Figure 3A, induction with
IPTG resulted in high level expression of wild-type or
mutant C protein from the T7 promoter, as demonstrated
by an intense band corresponding to C protein on the gel.
Some mutants gave over-expressed C protein with the
same migration as wild-type C, for example, Figure 3A—
mutant 77. Others produced protein which appeared
to be larger or smaller than wild-type C, for example,
Figure 3A—mutants 148 and 254. Others showed no
over-expressed protein band at all (data not shown), sug-
gesting that the C protein made was unstable and rapidly
degraded. For the mutants that produced an intense pro-
tein band with a migration similar to that of wild-type C,
the C gene was sequenced on both strands within and
beyond the entire cloned cassette. Figure 2E shows the
locations of the mutations and identity of mutant proteins
with single amino acid changes.
Gel retardation assay
A gel mobility shift assay was used to test the DNA-bind-
ing ability of the mutant proteins with single amino acid
substitutions. Crude cell extracts containing roughly simi-
lar amounts of overproduced C protein were assayed for
binding to a wild-type promoter DNA fragment contain-
ing Plys
S ( 52 to +8). All of the mutant proteins (identi-
ﬁed in Figure 2E) were defective in DNA binding as
reﬂected by the absence of a detectable shifted band.
Figure 3B shows representative results from gel-shift
assays of two such mutants. Most mutant proteins gave
results similar to those for protein 110ST (Figure 3B),
that is, no detectable DNA binding. Approximately one-
third gave results similar to those for protein 115YD
(Figure 3B), which we interpret as weak unstable binding.
Transactivation assay
A more quantitative assessment of the transactivation abil-
ity of the mutant C proteins was obtained by transforma-
tion of the mutant plasmids into E. coli strain MH13708
containing the Plys-lacZ reporter plasmid pLC18
S and per-
forming liquid b-galactosidase assays. All assays were done
in parallel with strains containing pYJ18 (wild-type C) and
pYJ38 (C gene deleted) as positive and negative controls,
respectively. These results showed that all the DNA-
binding defective mutants are severely defective in transac-
tivation, producing less than 5% of wild-type levels of
transactivation (data not shown).
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The results presented here demonstrate that the b-strand
and HTH regions of C protein are important for its
DNA binding and transactivation functions. Mutations
in regions II and III are located within or just downstream
of the predicted HTH DNA-binding motif characteristic of
many transcription regulators [for reviews see (32,47–50)].
In the crystal structure of Mor, the analogous residues
make up helices a4 and a5 in the three-helix bundle
of the HTH domain (29). In the well characterized
20 amino acid HTH motif (30–32), amino acids at posi-
tions 4, 8, 10, 15 and 18 are usually hydrophobic, and both
Mor and C have hydrophobic residues at these positions.
For C these residues are 103L, 107Y, 109L, 114I and 117I.
Thus the severe DNA-binding defects caused by muta-
tions 109LR and 114IN are consistent with their predicted
roles in forming the hydrophobic core of the HTH
domain. In many HTH proteins, amino acids in the turn
and ﬁnal helix (a5 of Mor) of the HTH make important
contacts within the two successive DNA major grooves,
leading to its designation as the recognition helix (32). The
structural similarity between the Mor HTH domain and
that of TrpR led to the prediction that the Mor HTH
would contact the DNA in an ‘ends-on’ manner, using
amino acids in the turn and N-terminus of a5 for these
contacts (29). The analogous C amino acids correspond to
110S–116Q; their involvement is supported by the DNA
binding defects caused by mutations 110ST, 113QP,
114IN and 115YD. Taken together, these results provide
strong support for the prediction that the C-terminal one-
third of C contains an HTH motif which is required for
DNA binding.
A number of HTH and non-HTH DNA-binding pro-
teins use more than one motif for DNA binding, with the
secondary motif often interacting in the DNA minor
groove (48–50). The mutations in region I correspond to
residues within or ﬂanking the two b-strands observed in
the crystal structure of the Mor dimer (Figure 2A and B;
29) and may identify such a secondary binding motif in the
Mor/C family of proteins (29). In the Mor structure this
region serves as a linker between the dimerization and
HTH domains and contains ﬁve invariant amino acids
and two highly conserved hydrophobic residues. These
correspond to invariant C amino acids 70G, 71G, 75Y,
77P and 79G as well as conserved hydrophobic residues
at 74F and 76I (Figure 1B). Since the N-terminal residues
of Mor a5 that are predicted to bind in two successive
major grooves of the DNA are too far apart to reach
them (Figure 2D), Kumaraswami et al. (29) proposed
that the conserved glycines provide pivot points for con-
formational changes that move the HTH domains from
their original positions beside the dimerization domain to
new positions above it in order for the HTH motifs to
contact the DNA major grooves (Figure 2D). This
change would bring the b-strand and nearby amino
acids of C into close proximity with the DNA minor
groove, explaining why the glycine residues are invariant
and potentially allowing interaction of the 73Q and 75Y
residues with the minor groove (Figure 2D). Consistent
with this hypothesis, footprinting with the minor groove-
speciﬁc chemical nuclease 1, 10-phenanthroline copper
showed that interaction of C with its binding site
in Pmom prevented minor groove cleavages seen in
the absence of C (22). Binding of both Mor and C pro-
teins produces a  408 bend in the DNA (21,26) and
Kumaraswami et al. (29) predicted that the DNA will
bend away from the protein. Such bends are often gener-
ated by intercalation of one or more hydrophobic amino
Figure 3. (A) Mutant protein screening by SDS-PAGE. Mutant C proteins were over-expressed by IPTG induction of T7 RNAP expression in cells
containing C mutant derivatives (numbered above each lane) of the expression vector pYJ18. Cell extracts were subjected to electrophoresis in 15%
PAGE in Tris-glycine buﬀer for  4hr and then stained with Coomassie blue R250. Lanes ‘U’ and ‘I’ contain extracts from uninduced and induced cells,
respectively, making wild-type C protein. The arrow points to a C protein band of wild-type length. (B) Representative gel shift assay for DNA binding.
Two-fold serial dilutions of crude extract containing similar amounts of mutant or wild-type C protein were incubated for 15min at 258C with a
32P-labeled PCR fragment containing Plys sequence from  52 to +8, then subjected to electrophoresis in the cold for  3hr. Free probe (F) and
bound complexes (B) were detected by autoradiography. All the panels came from a single gel, but three lanes between 115YD and WT C were removed.
Nucleic Acids Research, 2008, Vol. 36, No. 20 6403acid side chains between the base pairs (51–55). The bend
angle is dependent on the size and length of the amino acid
side chain and the depth of its insertion into the DNA
minor groove, generating bends as small as 208 and as
large as 1808 (51–55). The b-strand in Mor has 68Q and
70Y side chains extending out from the surface of the
protein (Figure 2B) and 69V, 71I and 72P pointing into
the protein, forming a cap on the hydrophobic dimeriza-
tion domain (29). This cap may be retained in the DNA-
bound Mor or one or more of its residues may intercalate
into the minor groove. These residues correspond to C
amino acids 73Q and 75Y pointing out and hydrophobic
residues 74F, 76I and 77P, respectively. Taken together,
these arguments explain the serious DNA binding defects
caused by mutations 73QL, 77PL and 77PT.
ACKNOWLEDGEMENTS
Oligonucleotides were synthesized by the University of
Tennessee Molecular Resource Center on an Applied
Biosystems DNA synthesizer (Model 380B) using the
phosphoramidite method (40).
FUNDING
Van Vleet Chair of Excellence in Virology and College of
Medicine, University of Tennessee Health Science Center
(partial); National Science Foundation Grants (MCB-
9305924, MCB-9604653 and MCB-0418108). Funding
for open access charge: Van Vleet Chair of Excellence in
Virology.
Conﬂict of interest statement. None declared.
REFERENCES
1. Symonds,N.A., Toussaint,A., van de Putte,P. and Howe,M.M.
(1987) Phage Mu. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, N.Y.
2. Howe,M.M. (1997) Bacteriophage Mu. In Busby,S.J.W.,
Thomas,C.M. and Brown,N.L. (eds), Molecular Microbiology.
Spring-Verlag, Heidelberg, pp. 65–80.
3. Paolozzi,L. and Ghelardini,P. (2006) The Bacteriophage Mu. In
Calendar,R. (ed.), The Bacteriophages. Oxford University Press,
New York, NY, pp. 469–496.
4. Goosen,N. and van de Putte,P. (1987) Regulation of transcription.
In Symonds,N., Toussaint,A., van de Putte,P. and Howe,M.M.
(eds), Phage Mu. Cold Spring Harbor Laboratory Press, Cold
Spring Harbor, NY, pp. 41–52.
5. Stoddard,S.F. and Howe,M.M. (1989) Localization and regulation
of bacteriophage Mu promoters. J. Bacteriol., 171, 3440–3448.
6. Marrs,C.F. and Howe,M.M. (1990) Kinetics and regulation of
transcription of bacteriophage Mu. Virology, 174, 192–203.
7. Toussaint,A. and Lecocq,J.-P. (1974) Sensitivity of bacteriophage
Mu-1 development to rifampicin and streptolydigin. Mol. Gen.
Genet., 129, 185–188.
8. Wijﬀelman,C. and van de Putte,P. (1974) Transcription of bacter-
iophage Mu: an analysis of transcription pattern in the early stage
of phage development. Mol. Gen. Genet., 135, 327–337.
9. Mathee,K. and Howe,M.M. (1990) Identiﬁcation of a positive
regulator of the Mu middle operon. J. Bacteriol., 172, 6641–6650.
10. Hattman,S., Ives,J., Margolin,W. and Howe,M.M. (1985)
Regulation and expression of the bacterio-phage Mu mom gene:
mapping of the transactivation (Dad) function to the C region.
Gene, 39, 71–76.
11. Heisig,P. and Kahmann,R. (1986) The sequence and mom-transac-
tivation function of the C gene of bacteriophage Mu. Gene, 43,
59–67.
12. Margolin,W., Rao,G. and Howe,M.M. (1989) Bacteriophage Mu
late promoters: four late transcripts initiate near a conserved
sequence. J. Bacteriol., 171, 2003–2018.
13. Margolin,W. and Howe,M.M. (1986) Localization and DNA
sequence analysis of the C gene of bacteriophage Mu, the positive
regulator of Mu late transcription. Nucleic Acids Res., 14,
4881–4897.
14. Margolin,W. and Howe,M.M. (1990) Activation of the bacter-
iophage Mu lys promoter by Mu C protein requires the s70 subunit
of Escherichia coli RNA polymerase. J. Bacteriol., 172, 1424–1429.
15. Bolker,M.F., Wulczyn,G. and Kahmann,R. (1989) Role of bacter-
iophage Mu C protein in activation of the mom gene promoter.
J. Bacteriol., 171, 2019–2027.
16. Harley,C.B. and Reynolds,R.P. (1987) Analysis of E. coli promoter
sequences. Nucl. Acids Res., 15, 2343–2361.
17. Hawley,D.K. and McClure,W.R. (1983) Compilation and analysis
of Escherichia coli promoter DNA sequences. Nucl. Acids Res., 11,
2237–2255.
18. Balke,V., Nagaraja,V., Gindlesperger,T. and Hattman,S. (1992)
Functionally distinct RNA polymerase binding sites in the phage
Mu mom promoter region. Nucleic Acids Res., 20, 2777–2784.
19. Zhao,Z. (1999) Eﬀects of Plys promoter sequence on transcription
activation by the C protein of bacteriophage Mu. Ph.D. Thesis.
The University of Tennessee, Memphis.
20. Chiang,L.W. and Howe,M.M. (1993) Mutational analysis of a
C-dependent late promoter of bacteriophage Mu. Genetics, 135,
619–629.
21. Sun,W., Hattman,S. and Kool,E. (1997) Interaction of the bacter-
iophage Mu transcriptional activator protein, C, with its target site
in the mom promoter. J. Mol. Biol., 273, 765–774.
22. Ramesh,V. and Nagaraja,V. (1996) Sequence-speciﬁc DNA
binding of the phage Mu C protein: footprinting analysis reveals
altered DNA conformation upon protein binding. J. Mol. Biol.,
260, 22–33.
23. Sun,W., Hattman,S., Fujita,N. and Ishihama,A. (1998) Activation
of bacteriophage Mu mom transcription by C protein does not
require speciﬁc interaction with the carboxyl-terminal region of the
alpha or sigma-70 subunit of Escherichia coli RNA polymerase.
J. Bacteriol., 180, 3257–3259.
24. Artsimovitch,I., Murakami,K., Ishihama,A. and Howe,M.M.
(1996a) Transcription activation by the bacteriophage Mu Mor
protein requires the C-terminal regions of both alpha and sigma70
subunits of Escherichia coli RNA polymerase. J. Biol. Chem., 271,
32343–32348.
25. Artsimovitch,I., Kahmeyer-Gabbe,M. and Howe,M.M. (1996b)
Distortion in the spacer region of Pm during activation of middle
transcription of phage Mu. Proc. Natl. Acad. Sci. USA, 93,
9408–9413.
26. Artsimovitch,I. and Howe,M.M. (1996) Transcription activation by
the bacteriophage Mu Mor protein: analysis of promoter mutations
in Pm identiﬁes a new region required for promoter function.
Nucleic Acids Res., 24, 450–457.
27. Chakraborty,A. and Nagaraja,V. (2006) Dual role for transactiva-
tor protein C in activation of mom promoter of bacteriophage Mu.
J. Biol. Chem., 281, 8511–8517.
28. Altschul,S.F., Gish,W., Miller,W., Myers,E.W. and Lipman,D.J.
(1990) Basic local alignment search tool. J. Mol. Biol., 215, 403–410.
29. Kumaraswami,M., Howe,M.M. and Park,H.W. (2004) Crystal
structure of the Mor protein of bacteriophage Mu, a member of the
Mor/C family of transcription activators. J. Biol. Chem., 279,
16581–16590.
30. Dodd,I.A. and Egan,J.B. (1987) Systematic method for the detec-
tion of potential  Cro-like DNA-binding regions in proteins.
J. Mol. Biol., 194, 557–564.
31. Dodd,I.A. and Egan,J.B. (1990) Improved detection of helix-turn-
helix DNA-binding motifs in protein sequences. Nucleic Acids Res.,
18, 5019–5026.
32. Brennan,R.G. and Matthews,B.W. (1989) The helix-turn-helix DNA
binding motif. J. Biol. Chem., 264, 1903–1906.
33. Miller,F.H. (1972) Experiments in Molecular Genetics. Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, New York.
6404 Nucleic Acids Research, 2008, Vol. 36, No. 2034. Nikaido,H. (1961) Galactose-sensitive mutants of Salmonella. I.
Metabolism of galactose. Biochim. Biophys. Acta, 48, 460–469.
35. Simons,R.W., Houman,F. and Kleckner,N. (1987) Improved single
and multicopy lac-based cloning vectors for protein and operon
fusions. Gene, 53, 85–96.
36. Chang,A.C. and Cohen,S.N. (1978) Construction and characteri-
zation of ampliﬁable multicopy DNA cloning vehicles derived from
the P15A cryptic miniplasmid. J. Bacteriol., 134, 1141–1156.
37. Rose,R.E. (1988) The nucleotide sequence of pACYC177. Nucleic
Acids Res., 16, 356–359.
38. McKenney,K., Shimatake,H., Court,D., Schmeissner,U., Brady,C.
and Rosenberg,M. (1981) A system to study promoter and terminator
signals recognized by Escherichia coli RNA polymerase. In Chirikjian
J.G. and Papas T.S. (eds), Gene Ampliﬁcation and Analysis, Vol. II.
Elsevier/North-Holland, New York, N.Y, pp. 383–415.
39. Sutcliﬀe,J.G. (1979) Complete nucleotide sequence of the
Escherichia coli plasmid pBR322. Cold Spring Harb. Symp. Quant.
Biol., 43, 77–90.
40. Beaucage,S.L. and Caruthers,M.H. (1981) Studies on nucleotide
chemistry V. Deoxynucleoside phosphoramidites—a new class of
key intermediates for deoxypolynucleotide synthesis. Tetrahedron
Lett., 22, 1859–1862.
41. Hermes,J.D., Parekh,S.M., Blacklow,S.C., Koster,H. and
Knowles,J.R. (1989) A reliable method for random mutagenesis: the
generation of mutant libraries using spiked oligodeoxyribonucleo-
tide primers. Gene, 84, 143–151.
42. Laemmli,U.K. (1970) Cleavage of structural proteins during the
assembly of the head of the bacteriophage T4. Nature, 227,
680–682.
43. Sambrook,J., Fritsch,E.F. and Mantiatis,T. (1989) Molecular
Cloning A Laboratory Manual, 2nd edn. Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY.
44. Carey,J. (1991) Gel retardation. Methods Enzymol., 208, 103–117.
45. Maniatis,T., Fritsch,E.F. and Sambrook,J. (1982) Molecular
Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory
Press, Cold Spring Harbor, New York.
46. Chiang,L.W., Kovari,I. and Howe,M.M. (1993) Mutagenic
oligonucleotide-directed PCR ampliﬁcation (Mod-PCR): an
eﬃcient method for generating random base substitution mutations
in a DNA sequence element. PCR Methods Appl., 2, 210–217.
47. Aravind,L., Anantharaman,V., Balaji,S., Babu,M.M. and Iyer,L.M.
(2005) The many faces of the helix-turn-helix domain: transcription
regulation and beyond. FEMS Microbiol. Rev., 29, 231–262.
48. Wintjens,R. and Rooman,M. (1996) Structural classiﬁcation of
HTH DNA-binding domains and protein-DNA interaction modes.
J. Mol. Biol., 262, 294–313.
49. Jones,S., van Heyningen,P., Berman,H.M. and Thornton,J.M.
(1999) Protein-DNA interactions: a structural analysis. J. Mol.
Biol., 287, 877–896.
50. Luscombe,N.M., Austin,S.E., Berman,H.M., and Thornton,J.M.
(2000) An overview of the structures of protein-DNA complexes.
Genome Biol., 1, REVIEWS001.
51. Rice,P.A., Yang,S., Mizuuchi,K. and Nash,H.A. (1996) Crystal
structure of an IHF-DNA complex: a protein-induced DNA
U-turn. Cell, 87, 1295–1306.
52. Bewley,C.A., Gronenborn,A.M. and Clore,G.M. (1998) Minor-
groove binding architectural proteins: structure, function, and
DNA recognition. Annu. Rev. Biophys. Biomol. Struct., 27,
105–131.
53. Klass,J., Murphy,F.V. IV, Fouts,S., Serenil,M., Changela,A.,
Siple,J. and Churchill,M.E.A. (2003) The role of intercalating resi-
dues in chromosomal high-mobility-group protein DNA binding,
bending and speciﬁcity. Nucleic Acids Res., 31, 2852–2864.
54. Chen,C.-Y., Ko,T.-P., Lin,T.-W., Chou,C.-C., Chen,C.-J. and
Wang,A.H.-J. (2005) Probing the DNA kink structure induced by
the hyperthermophilic chromosomal protein Sac7d. Nucleic Acids
Res., 33, 430–438.
55. Stott,K., Tang,G.S.F., Lee,K-B. and Thomas,J.O. (2006) Structure
of a complex of tandem HMG boxes and DNA. J. Mol. Biol., 360,
90–104.
56. Gindlesperger,T.L. and Hattman,S. (1994) In vitro transcriptional
activation of the phage Mu mom promoter by C protein.
J. Bacteriol., 176, 2885–2891.
57. Rost,B. (1996) PHD: predicting one-dimensional protein structure
by proﬁle-based neural networks. Methods in Enzymol., 266,
525–539.
Nucleic Acids Research, 2008, Vol. 36, No. 20 6405